Literature DB >> 21157370

Early cardiac gene transcript levels in peripheral blood mononuclear cells in patients with untreated essential hypertension.

Joanna E Kontaraki1, Maria E Marketou, Evangelos A Zacharis, Fragiskos I Parthenakis, Panos E Vardas.   

Abstract

OBJECTIVES: To assess the expression of early cardiac genes, implicated in the hypertrophic growth response of the adult heart, in peripheral blood mononuclear cells in patients with essential hypertension and its relationship to ambulatory blood pressure monitoring (ABPM) parameters and to echocardiographic left ventricular mass.
METHODS: Twenty-four-hour ABPM, echocardiography and blood sampling were performed in 62 untreated participants with essential hypertension. Blood samples from 38 healthy individuals were included for comparison. Peripheral blood mononuclear cells (PBMCs) were isolated and gene transcript levels were determined by quantitative real-time reverse transcription PCR.
RESULTS: Myocardin (3.92±0.68 versus 2.09±0.67, P<0.001), GATA4 (3.48±0.68 versus 0.32±0.08, P<0.001) and Nkx2.5 (208.91±35.01 versus 129.75±49.70, P<0.001) were upregulated in hypertensive patients compared with controls. In hypertensive patients, transcript levels of myocardin (r=0.698, P<0.001) and GATA4 (r=0.374, P=0.003) showed significant positive correlations with 24-h systolic blood pressure (BP) as well as with mean BP, (r=0.626, P<0.001) and (r=0.340, P=0.007), respectively. A significant positive correlation between myocardin and 24-h pulse pressure (r=0.467, P<0.001) was also observed. Myocardin (r=-0.606, P<0.001) and GATA4 (r=-0.453, P<0.001) transcript levels also showed significant negative correlations with the mean 24-h dipping status. Additionally, myocardin (r=0.341, P=0.007), GATA4 (r=0.337, P=0.007) and Nkx2.5 (r=0.325, P=0.010) transcript levels showed significant positive correlations with left ventricular mass index.
CONCLUSION: Myocardin and GATA4 transcript levels correlate significantly with 24-h ABPM parameters, rendering them potential candidate biomarkers in hypertension. Early cardiac gene transcript levels in PBMCs of hypertensive patients are associated with left ventricular mass and may reflect activation of the hypertrophic response gene network in these patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21157370     DOI: 10.1097/HJH.0b013e3283424bc4

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  9 in total

1.  Differential expression of vascular smooth muscle-modulating microRNAs in human peripheral blood mononuclear cells: novel targets in essential hypertension.

Authors:  J E Kontaraki; M E Marketou; E A Zacharis; F I Parthenakis; P E Vardas
Journal:  J Hum Hypertens       Date:  2013-11-28       Impact factor: 3.012

2.  Increased mobilization of mesenchymal stem cells in patients with essential hypertension: the effect of left ventricular hypertrophy.

Authors:  Maria E Marketou; Fragiskos I Parthenakis; Athanasia Kalyva; Charalampos Pontikoglou; Spyros Maragkoudakis; Joanna E Kontaraki; Evangelos A Zacharis; Gregory Chlouverakis; Alexandros Patrianakos; Helen A Papadaki; Panos E Vardas
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-10-20       Impact factor: 3.738

3.  Functional epistatic interaction between rs6046G>A in F7 and rs5355C>T in SELE modifies systolic blood pressure levels.

Authors:  Said El Shamieh; Ndeye Coumba Ndiaye; Maria G Stathopoulou; Helena A Murray; Christine Masson; John V Lamont; Peter Fitzgerald; Athanase Benetos; Sophie Visvikis-Siest
Journal:  PLoS One       Date:  2012-07-18       Impact factor: 3.240

4.  In search of novel targets for heart disease: myocardin and myocardin-related transcriptional cofactors.

Authors:  Alexander T Mikhailov; Mario Torrado
Journal:  Biochem Res Int       Date:  2012-05-17

Review 5.  Myocardin in biology and disease.

Authors:  Joseph M Miano
Journal:  J Biomed Res       Date:  2014-12-25

6.  The Formin, DIAPH1, is a Key Modulator of Myocardial Ischemia/Reperfusion Injury.

Authors:  Karen M O'Shea; Radha Ananthakrishnan; Qing Li; Nosirudeen Quadri; Devi Thiagarajan; Gopalkrishna Sreejit; Lingjie Wang; Hylde Zirpoli; Juan Francisco Aranda; Arthur S Alberts; Ann Marie Schmidt; Ravichandran Ramasamy
Journal:  EBioMedicine       Date:  2017-11-21       Impact factor: 8.143

7.  DNA methylation signatures associated with cardiometabolic risk factors in children from India and The Gambia: results from the EMPHASIS study.

Authors:  Elie Antoun; Prachand Issarapu; Caroline H D Fall; Matt J Silver; Giriraj R Chandak; Karen A Lillycrop; Chiara di Gravio; Smeeta Shrestha; Modupeh Betts; Ayden Saffari; Sirazul A Sahariah; Alagu Sankareswaran; Manisha Arumalla; Andrew M Prentice
Journal:  Clin Epigenetics       Date:  2022-01-09       Impact factor: 6.551

Review 8.  Pathological Left Ventricular Hypertrophy and Stem Cells: Current Evidence and New Perspectives.

Authors:  Maria E Marketou; Fragiskos Parthenakis; Panos E Vardas
Journal:  Stem Cells Int       Date:  2015-12-20       Impact factor: 5.443

Review 9.  ROCK (RhoA/Rho Kinase) in Cardiovascular-Renal Pathophysiology: A Review of New Advancements.

Authors:  Teresa M Seccia; Matteo Rigato; Verdiana Ravarotto; Lorenzo A Calò
Journal:  J Clin Med       Date:  2020-05-02       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.